Donate

Media center

At PATH, our global health experts are developing partnerships, new devices, and solutions to the world's most pressing health needs. Contact us to speak with one of PATH's experts today.

Contact Us

Senior Director of Marketing & Communications:
Lauren Grella

Email: media@path.org

PATH is advancing health equity around the world

December 19, 2025
The appeal of a dual-parasite combination vaccine
December 19, 2025
The future looks bright for malaria prevention
December 4, 2025
Disease outbreak survivors are key to future preparedness

Featured Press Coverage

April 18, 2024
Millions of Girls in Africa Will Miss HPV Shots After Merck Production Problem
The New York Times
November 19, 2025
Can AI safely support mental health?
Devex
February 12, 2024
Could new vaccines end malaria in Africa?
Al Jazeera

Recent Press Coverage

  1. Brazil’s Success in Preventing Malaria Relapse Using New Single-Dose Treatment
    Learn about a new point-of-care test, developed by SD Biosensor and PATH, that could identify a hereditary condition that can cause hemolytic anemia in those who take tafenoquine.
    Published: July 2023
  2. Global Vaccine Research Collaborative Could Pave The Way For Faster Pandemic Response
    The global response to the COVID-19 pandemic was beset with several challenges, but one bright spot stood out: the whole vaccine research and development pipeline was accomplished in just under 300 days, an unprecedented timeline.
    Published: June 2023
  3. The status of Kenya’s medical oxygen infrastructure
    The COVID-19 pandemic highlighted the urgent need to scale up medical oxygen systems. In Kenya, oxygen availability varies depending on the location and facility. PATH’s Lisa Smith spoke with Nation about how to increase access to medical oxygen.
    Published: June 2023
  4. New vaccine trials show promise in fight against meningitis
    A new meningitis vaccine, developed by PATH and the Serum Institute of India, has shown promise in the fight against the disease, eliciting immune responses against five main strains.
    Published: May 2023
Previous
Next

We develop evidence-based expertise and resources

Our global team leverages data and evidence to develop resources and innovations that bring good health to more people.

Explore our evidence

Join the latest discussions on health equity.

We partner with the public and private sector, government, and academia from around the world to share insightful conversations on the latest topics affecting health equity.

Explore PATH events

PATH Newsroom

Related articles

Read our latest

989 Item s
989 Item s
    Date
    From
    To
  1. Join PATH and the HepC3P project at the 14th International Conference on Health and Hepatitis in Substance Users
    At the 14th International Conference on Health and Hepatitis in Substance Users, PATH will highlight our work introducing innovative Hepatitis C virus prevention products and approaches, as well as roadmaps for advancing essential harm reduction services globally.
    Published: September 2026
    Press Release
  2. PATH and Global Fund take stock of antimalarial efficacy studies
    The Global Fund to Fight AIDS, Tuberculosis, and Malaria selects PATH to landscape, assess, and support antimalarial therapeutic efficacy studies across Sub-Saharan Africa.
    Published: September 2026
    Announcement
  3. PATH selected to lead Global Fund Integrated Surveillance grant
    The Global Fund to Fight AIDS, Tuberculosis and Malaria selects PATH to lead the Sustainable and Integrated Data Systems grant to support integration efforts in Zambia, Senegal, and Ghana.
    Published: September 2026
    Announcement
  4. PATH appoints Dr. Jeremy Farrar as Chief of Asia, Middle East, and Europe regional division
    Published: September 2026
    Press Release
  5. New SARS-CoV-1 antibody available for vaccine researchers
    Targeted antibodies can speed the development and testing of vaccines globally.
    Published: September 2026
    Press Release
Next